{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T06:59:15Z","timestamp":1782197955279,"version":"3.54.5"},"reference-count":28,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2007,7,1]],"date-time":"2007-07-01T00:00:00Z","timestamp":1183248000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Virus Research"],"published-print":{"date-parts":[[2007,7]]},"DOI":"10.1016\/j.virusres.2007.03.016","type":"journal-article","created":{"date-parts":[[2007,4,24]],"date-time":"2007-04-24T16:26:20Z","timestamp":1177431980000},"page":"43-48","source":"Crossref","is-referenced-by-count":10,"title":["Rabbits immunised with recombinant BCG expressing the cottontail rabbit papillomavirus (CRPV) L2E7E2 genes induces regression of established papillomas"],"prefix":"10.1016","volume":"127","author":[{"given":"V.A.","family":"Govan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.-L.","family":"Williamson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.virusres.2007.03.016_bib1","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1006\/viro.2000.0265","article-title":"Interaction of the papillomavirus E2 protein with mitotic chromosomes","volume":"270","author":"Bastien","year":"2000","journal-title":"Virology"},{"key":"10.1016\/j.virusres.2007.03.016_bib2","doi-asserted-by":"crossref","unstructured":"Brandsma, J.L., Shlyankevich, M., Buonocore, L., Roberts, A., Becker, S.M., Rose, J.K., 2006. Therapeutic efficacy of vesicular stomatitis virus-based E6 vaccination in rabbits. Vaccine. August 22 (Epub ahead of print).","DOI":"10.1016\/j.vaccine.2006.08.012"},{"key":"10.1016\/j.virusres.2007.03.016_bib3","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1128\/JVI.78.1.116-123.2004","article-title":"Vaccination of rabbits with an adenovirus vector expressing the papillomavirus E2 protein leads to clearance of papillomas and infection","volume":"78","author":"Brandsma","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2007.03.016_bib4","doi-asserted-by":"crossref","first-page":"3456","DOI":"10.1016\/S0264-410X(02)00350-X","article-title":"Enhancement of human papillomavirus (HPV) type 16 E6- and E7-specific T-cell immunity in healthy volunteers through vaccination with TA-CIN, an HPV16 L2E7E6 fusion protein vaccine","volume":"20","author":"de Jong","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.virusres.2007.03.016_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1517\/14712598.4.8.1251","article-title":"Advances in the development of therapeutic nucleic acids against cervical cancer","volume":"4","author":"DiPaolo","year":"2004","journal-title":"Exp. Opin. Biol. Ther."},{"key":"10.1016\/j.virusres.2007.03.016_bib6","series-title":"IARC CancerBase No. 5, version 2.0","article-title":"GLOBOCAN 2002 cancer incidence. Mortality and prevalence worldwide","author":"Ferlay","year":"2004"},{"key":"10.1016\/j.virusres.2007.03.016_bib7","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1111\/j.1525-1438.2006.00598.x","article-title":"Prime-boost vaccination strategy in women with high-grade, noncervical anogenital intraepithelial neoplasia: clinical results from a multicenter phase II trial","volume":"16","author":"Fiander","year":"2006","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.virusres.2007.03.016_bib8","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/nri1260","article-title":"Prevention of cervical cancer through papillomavirus vaccination","volume":"4","author":"Frazer","year":"2004","journal-title":"Nature Rev. Immunol."},{"key":"10.1016\/j.virusres.2007.03.016_bib9","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S1473-3099(03)00720-5","article-title":"Papillomavirus vaccines in clinical trials","volume":"3","author":"Galloway","year":"2003","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.virusres.2007.03.016_bib10","doi-asserted-by":"crossref","first-page":"4287","DOI":"10.1128\/IAI.62.10.4287-4295.1994","article-title":"Mycobacterium bovis BCG priming induces a strong potentiation of the antibody response induced by recombinant BCG expressing a foreign antigen","volume":"62","author":"Gheorghiu","year":"1994","journal-title":"Infect. Immun."},{"key":"10.1016\/j.virusres.2007.03.016_bib11","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1196\/annals.1352.016","article-title":"Strategies for human papillomavirus therapeutic vaccines and other therapies based on the e6 and e7 oncogenes","volume":"1056","author":"Govan","year":"2005","journal-title":"Ann. NY Acad. Sci."},{"key":"10.1016\/j.virusres.2007.03.016_bib12","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1016\/j.vaccine.2005.11.029","article-title":"Immunisation with recombinant BCG expressing the cottontail rabbit papillomavirus (CRPV) L1 gene provides protection from CRPV challenge","volume":"24","author":"Govan","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.virusres.2007.03.016_bib13","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1016\/S0264-410X(98)00356-9","article-title":"Intramuscular injection of plasmid DNA encoding cottontail rabbit papillomavirus E1, E2, E6 and E7 induces T cell-mediated but not humoral immune responses in rabbits","volume":"17","author":"Han","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.virusres.2007.03.016_bib14","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.1016\/S0264-410X(99)00550-2","article-title":"Immune responses induced by BCG recombinant for human papillomavirus L1 and E7 proteins","volume":"18","author":"Jabbar","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.virusres.2007.03.016_bib15","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/0264-410X(94)90054-X","article-title":"Cytotoxic T lymphocyte response in mice induced by a recombinant BCG vaccination which produces an extracellular alpha antigen that fused with the human immunodeficiency virus type 1 envelope immunodominant domain in the V3 loop","volume":"12","author":"Kameoka","year":"1994","journal-title":"Vaccine"},{"key":"10.1016\/j.virusres.2007.03.016_bib16","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/S0264-410X(02)00465-6","article-title":"Combined intrarectal\/intradermal inoculation of recombinant Mycobacterium bovis bacillus Calmette-Guerin (BCG) induces enhanced immune responses against the inserted HIV-1 V3 antigen","volume":"21","author":"Kawahara","year":"2002","journal-title":"Vaccine"},{"issue":"Suppl. 3","key":"10.1016\/j.virusres.2007.03.016_bib17","doi-asserted-by":"crossref","first-page":"S114","DOI":"10.1016\/j.vaccine.2006.06.014","article-title":"Current findings from prophylactic HPV vaccine trials","author":"Koutsky","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.virusres.2007.03.016_bib18","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.vaccine.2006.06.015","article-title":"Burden and management of non-cancerous HPV-related conditions: HPV-6\/11 disease","volume":"24","author":"Lacey","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.virusres.2007.03.016_bib19","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.vaccine.2006.05.115","article-title":"HPV in the etiology of human cancer","volume":"24S3","author":"Munoz","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.virusres.2007.03.016_bib20","doi-asserted-by":"crossref","first-page":"5516","DOI":"10.1016\/j.vaccine.2006.04.058","article-title":"Protection of rabbits against cutaneous papillomavirus infection using recombinant tobacco mosaic virus containing L2 capsid epitopes","volume":"24","author":"Palmer","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.virusres.2007.03.016_bib21","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1016\/j.vaccine.2006.05.111","article-title":"The burden of HPV-related cancers","volume":"3","author":"Parkin","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.virusres.2007.03.016_bib22","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1006\/viro.2000.0272","article-title":"Minor capsid protein of human genital papillomaviruses contains subdominant, cross-neutralizing epitopes","volume":"270","author":"Roden","year":"2000","journal-title":"Virology"},{"key":"10.1016\/j.virusres.2007.03.016_bib23","doi-asserted-by":"crossref","first-page":"S147","DOI":"10.1016\/j.vaccine.2006.05.123","article-title":"Second generation HPV vaccines to prevent cervical cancer","volume":"24","author":"Schiller","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.virusres.2007.03.016_bib24","doi-asserted-by":"crossref","first-page":"6987","DOI":"10.1073\/pnas.85.18.6987","article-title":"Lysogeny and transformation in mycobacteria: stable expression of foreign genes","volume":"85","author":"Snapper","year":"1988","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.virusres.2007.03.016_bib25","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1038\/351456a0","article-title":"New use of BCG for recombinant vaccines","volume":"351","author":"Stover","year":"1991","journal-title":"Nature"},{"key":"10.1016\/j.virusres.2007.03.016_bib26","doi-asserted-by":"crossref","first-page":"3652","DOI":"10.1016\/S0264-410X(01)00086-X","article-title":"Pre-clinical safety and efficacy of TA-CIN, a recombinant HPV16 L2E6E7 fusion protein vaccine, in homologous and heterologous prime-boost regimens","volume":"19","author":"van der Burg","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.virusres.2007.03.016_bib27","unstructured":"World Health Organisation (WHO), 2004. Vaccines against human papillomavirus. Available at: http:\/\/www.who.int\/vaccines\/en\/hpvrd.shtml\/shtml (accessed July 12)."},{"key":"10.1016\/j.virusres.2007.03.016_bib28","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/nrc798","article-title":"Papillomaviruses and cancer: from basic studies to clinical application","volume":"2","author":"zur Hausen","year":"2002","journal-title":"Nat. Rev. Cancer"}],"container-title":["Virus Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168170207001013?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168170207001013?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,21]],"date-time":"2020-04-21T13:59:14Z","timestamp":1587477554000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168170207001013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,7]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,7]]}},"alternative-id":["S0168170207001013"],"URL":"https:\/\/doi.org\/10.1016\/j.virusres.2007.03.016","relation":{},"ISSN":["0168-1702"],"issn-type":[{"value":"0168-1702","type":"print"}],"subject":[],"published":{"date-parts":[[2007,7]]}}}